Investors
To download our documents
Events
All events
Latest press releases
All press releases
Live stock price
OSE Immunotherapeutics is listed since 30th March 2015 on the regulated market of Euronext Paris
ISIN
FR0012127173
Ticker
OSE
Type of listing
Continuous
Number of outstanding shares
22,910,181 shares as of June 30, 2025
Eligibility
Eligible to Long-Only Deferred Settlement Service
Financial calendar
This calendar is indicative and may be amended. Financial results are published after market close (Euronext Growth Paris).
26 March 2025
Annual financial results 2024
25 September 2025
Cash position as of June 30, 2025
30 September 2025
General shareholders' meeting
15 October 2025
Full 2025 half-year interim financial results
